Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
20.15 HKD | +1.56% | +1.46% | -1.47% |
Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.47% | 7.79B | |
+13.59% | 69.43B | |
+5.67% | 26.07B | |
+5.02% | 7.98B | |
-27.52% | 7.13B | |
+0.18% | 4.52B | |
+21.54% | 4.39B | |
-2.45% | 3.98B | |
-4.54% | 3.82B | |
+23.90% | 3.64B |
- Stock Market
- Equities
- 1099 Stock
- News Sinopharm Group Co. Ltd.
- Sinopharm : WHO Grants Emergency-Use Approval to Sinovac's COVID-19 Vaccine